Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

Receive Latest News

Feedburner
Share Us

Effective Responses to FDA 483’s and Warning Letters

View: 77

Website https://www.demystifiedsolutions.com/trainingDetails/Effective-Responses-to-FDA-483’s-and-Warning-Le | Edit Freely

Category

Deadline: May 19, 2017 | Date: May 19, 2017

Venue/Country: Online

Updated: 2017-03-10 15:19:19 (GMT+9)

Call For Papers - CFP

When you receive an FDA-483 after your FDA inspection, how you respond can determine if FDA will send you a Warning Letter. If you receive an FDA Warning Letter citing violations, how you respond can determine if FDA will seek a Voluntary Injunction effectively putting you out of business.

In this webinar we will discuss the correct way to formulate your response to demonstrate to FDA that you have a complete understanding of the issues, and the corrective actions will prevent a recurrences of the violations.

Why Should You Attend

If your responsibility is responding to FDA-483’s and Warning Letter you must become familiar with the type of response that will satisfy FDA.Too often firms send incomplete (not well thought out) response to FDA either correcting and individual problem, not providing objective evidence, and/or providing unreasonable correction dates. It his happens with an FDA -484 FDA will either visit you again very soon, or you will get a Warning Letter. A poor response to Warning Letter can be disastrous.

Areas Covered in this Webinar

FDA policies on creating the FDA-483

FDA policy on issuing Warning Letters

Review example of Warning Letter Responses.

How to manage the creation of an effective response

Learning Objectives

What is an FDA-483?

Why does FDA issue Warning Letters?

How do you formulate an effective response?

Review recent FDA Warning Letter citations

How to determine if FDA is satisfied with your response.

Who Will Benefit

- QA Manager, Director or VP’s

- Regulatory Affairs Managers, Director, or VP

- Operations Managers, Directors or VP

- Corporate Compliance Personnel.

- Regulatory Consultants to the medical device industry

For More Info, Please Click below URL:

https://www.demystifiedsolutions.com/trainingDetails/Effective-Responses-to-FDA-483’s-and-Warning-Letters-DEMY050159


Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.